Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2002-3-28
pubmed:abstractText
To determine whether cryopreserved solutions of the thrombolytic agent alteplase could be used as a safe, effective, and economically reasonable alternative to urokinase in patients presenting with occluded central venous access devices (CVADs).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1918-22
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:11919252-Adolescent, pubmed-meshheading:11919252-Adult, pubmed-meshheading:11919252-Aged, pubmed-meshheading:11919252-Catheterization, Central Venous, pubmed-meshheading:11919252-Child, pubmed-meshheading:11919252-Child, Preschool, pubmed-meshheading:11919252-Cost-Benefit Analysis, pubmed-meshheading:11919252-Cryopreservation, pubmed-meshheading:11919252-Feasibility Studies, pubmed-meshheading:11919252-Female, pubmed-meshheading:11919252-Fibrinolytic Agents, pubmed-meshheading:11919252-Humans, pubmed-meshheading:11919252-Infant, pubmed-meshheading:11919252-Male, pubmed-meshheading:11919252-Middle Aged, pubmed-meshheading:11919252-Quality Control, pubmed-meshheading:11919252-Tissue Plasminogen Activator, pubmed-meshheading:11919252-United States, pubmed-meshheading:11919252-Venous Thrombosis
pubmed:year
2002
pubmed:articleTitle
Safe and cost effective use of alteplase for the clearance of occluded central venous access devices.
pubmed:affiliation
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. timoneyj@mskcc.org
pubmed:publicationType
Journal Article